PC-22

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePC-22
Drug Alias Nameanti-cancer agent (ProCell Therapeutics)PC-22
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionMetastasis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProcell Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProcell Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A